Taiwan FDA registration 8a35080d17aee66ebc23032c448230af
“RegenLab” RegenACR-C Plus Type I
TW: “利奇” 艾奇爾普樂絲第一型血球細胞分離套組
Taiwan·Risk Class 2·MD·REGEN LAB SA·Registered Apr 17, 2020 – Apr 17, 2025ExpiredRegistration details
- Analysis ID
- 8a35080d17aee66ebc23032c448230af
- License Form
- Ministry of Health Medical Device Import No. 033473
- Customs Code
- DHA05603347303
Company information
- Manufacturer
- REGEN LAB SA
- Manufacturer Country
- Switzerland
- Authorized Representative
- QUALTECH CONSULTING CORPORATION
Product details
- Intended Use
- This product is suitable for the preparation of autologous platelet thick fluid (PRP) and other plasma products (autologous thrombin serum).
- Product Type (Level 1)
- B Hematology and pathology devices
- Product Type (Level 2)
- B9245 Automatic Hematology Cell Separator
- Import Information
- Imported from abroad
Dates and status
- Registration Date
- Apr 17, 2020
- Expiry Date
- Apr 17, 2025
About this record
Access comprehensive regulatory information for “RegenLab” RegenACR-C Plus Type I in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 8a35080d17aee66ebc23032c448230af and manufactured by REGEN LAB SA. The authorized representative in Taiwan is QUALTECH CONSULTING CORPORATION.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices